Author details

Full Name

Noha Lim

Affiliation

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37502867	Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes.	medRxiv	2023
36041516	Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials.	J Immunol Methods	2022
34643650	Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial.	JAMA Dermatol	2021
34214479	Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.	Lancet Diabetes Endocrinol	2021
33658358	Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.	Sci Transl Med	2021
32841219	Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis.	JCI Insight	2020
31877116	Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis.	JCI Insight	2020
29456529	Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.	Front Immunol	2018
29087040	Reply to Christakoudi and Hernandez-Fuentes: We agree-Let's move on.	American Journal of Transplantation	2018
28196255	Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.	JAMA	2017
28498568	Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.	Clin Exp Immunol	2017
28844471	Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.	Cell Immunol	2017
28371372	B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.	Am J Transplant	2017
28881339	Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.	Am J Nephrol	2017
29348821	Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy.	Oncotarget	2017
29214037	Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis.	Lupus Sci Med	2017
28198767	Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs.	Transplantation	2017
26193635	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	J Clin Invest	2015
25332071	Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.	Arthritis Rheumatol	2015
25776953	Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.	Arthritis Rheumatol	2015
25891759	Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.	Arthritis Rheumatol	2015
26461968	Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.	Am J Transplant	2015
24531550	T cell repertoire following autologous stem cell transplantation for multiple sclerosis.	Journal of Clinical Investigation	2014
24622414	Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.	Lancet Diabetes Endocrinol	2013
23902481	Efficacy of remission-induction regimens for ANCA-associated vasculitis.	N Engl J Med	2013
20077255	Classification of high-dimensional data with ensemble of logistic regression models.	Journal of Biopharmaceutical Statistics	2010
20864672	Genetic variants influencing circulating lipid levels and risk of coronary artery disease.	Arterioscler Thromb Vasc Biol	2010
19060907	Variants in MTNR1B influence fasting glucose levels.	Nat Genet	2009
19557161	Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.	PLoS Genet	2009
19139842	Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study.	Diabetologia	2009
19079261	Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.	Nat Genet	2009
19430483	Genome-wide association study identifies eight loci associated with blood pressure.	Nat Genet	2009
19567438	Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.	JAMA	2009
18787507	Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes.	Pharmacogenet Genomics	2008
18940312	Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.	Am J Hum Genet	2008